Clinical trial
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
NCT00203567 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00203567 |
|---|---|
| Title | Carbamazepine Extended-Release for the Treatment of Bipolar Depression |
| Official title | Carbamazepine Extended-Release for the Treatment of Bipolar Depression |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | Shire Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Depression |
| Intervention type | Drug |
| Interventions | carbamazepine ER |
| Enrollment | 25 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: